When the Food and Drug Administration (FDA) authorized monoclonal antibodies, Allina Health started using it as early as January.
But the health system's lead physician for the treatment says most people declined it then. That's changing rapidly.
"Now almost 80% opt in to get it and 20% are declining it, so that's one change," says Dr. Venkat Iyer.